Cargando…

Rapid High-Level Production of Functional HIV Broadly Neutralizing Monoclonal Antibodies in Transient Plant Expression Systems

Passive immunotherapy using anti-HIV broadly neutralizing monoclonal antibodies (mAbs) has shown promise as an HIV treatment, reducing mother-to-child-transmission (MTCT) of simian/human immunodeficiency virus (SHIV) in non-human primates and decreasing viral rebound in patients who ceased receiving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenberg, Yvonne, Sack, Markus, Montefiori, David, Forthal, Donald, Mao, Lingjun, -Abanto, Segundo Hernandez, Urban, Lori, Landucci, Gary, Fischer, Rainer, Jiang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606348/ https://www.ncbi.nlm.nih.gov/pubmed/23533588 http://dx.doi.org/10.1371/journal.pone.0058724

Ejemplares similares

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015)

Enhanced HIV SOSIP Envelope yields in plants through transient co-expression of peptidyl-prolyl isomerase B and calreticulin chaperones and ER targeting
por: Rosenberg, Yvonne J., et al.
Publicado: (2022)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2016)

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
por: Hessell, Ann J., et al.
Publicado: (2009)

Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses
por: Eastman, Dawnnica, et al.
Publicado: (2008)

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
por: Ahmadi, Shirin, et al.
Publicado: (2020)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2019)

Broad neutralization of SARS-related viruses by human monoclonal antibodies
por: Wec, Anna Z., et al.
Publicado: (2020)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
por: Yasugi, Mayo, et al.
Publicado: (2013)

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
por: Tortorici, M. Alejandra, et al.
Publicado: (2021)

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
por: Shingai, Masashi, et al.
Publicado: (2014)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
por: Zhang, Zhigang, et al.
Publicado: (2021)

Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa
por: McKinley, Scott A., et al.
Publicado: (2014)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study
por: Gach, Johannes S., et al.
Publicado: (2014)

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance
por: Merat, Sabrina J., et al.
Publicado: (2016)

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
por: Owsianka, Ania M., et al.
Publicado: (2008)

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody
por: Gupta, Nimesh, et al.
Publicado: (2015)

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus
por: Kim, Pan Kyeom, et al.
Publicado: (2017)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
por: Wong, Yee Hwa, et al.
Publicado: (2018)

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
por: Ng, Cherie T., et al.
Publicado: (2010)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity
por: Rubio, Adonis A., et al.
Publicado: (2021)

A highly stable minimally processed plant-derived recombinant acetylcholinesterase for nerve agent detection in adverse conditions
por: Rosenberg, Yvonne J., et al.
Publicado: (2015)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
por: Ko, Hae Li, et al.
Publicado: (2023)

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody
por: Ye, Xiaohua, et al.
Publicado: (2016)

Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2009)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
por: Cortese, Mirko, et al.
Publicado: (2021)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
por: Zakir, Tasnim Saifudin, et al.
Publicado: (2022)

Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
por: Ling, Zhiyang, et al.
Publicado: (2022)

Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants
por: Guo, Hangtian, et al.
Publicado: (2023)

Dose–response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies
por: Webb, Nicholas E., et al.
Publicado: (2015)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020)

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
por: Engdahl, Taylor B., et al.
Publicado: (2021)

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
por: Engdahl, Taylor B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_se1em3ln13o7l5p3jgg55unmfm